aspirin has been researched along with etodolac in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (35.90) | 18.7374 |
1990's | 3 (7.69) | 18.2507 |
2000's | 10 (25.64) | 29.6817 |
2010's | 11 (28.21) | 24.3611 |
2020's | 1 (2.56) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Brozic, P; Gobec, S; Rizner, TL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Kumar, M; Sinha, VR; Thareja, S | 1 |
Bender, A; Czobor, P; Jelinek, B; Málnási-Csizmadia, A; Peragovics, Á; Simon, Z; Tombor, L; Végner, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Huang, S; Li, Y; Liu, W; Zhang, K; Zheng, X | 1 |
Bassleer, C; Franchimont, P; Henrotin, Y | 1 |
Pena, M | 1 |
Epstein, C; Jacob, G; Kennedy, J; Messina, M; Mullane, J; Sanda, M | 1 |
Epstein, C; Kinberg-Calhoun, J; Mullane, JF; Sanda, M; Shand, DG | 1 |
Brogden, RN; Lynch, S | 1 |
Lanza, F; Panagides, J; Salom, IL | 1 |
Crittenden, N; Fitzpatrick, F; McGee, J; McGuire, J | 1 |
Bilsback, P; Joubert, L; Merlo, M; Rolly, G; Versichelen, L | 1 |
Concepción, R; del Toro, RA | 1 |
Edwards, W | 1 |
Andelman, SY | 1 |
Hutton, CE | 1 |
Klicius, J; Martel, RR; Metcalf, G | 1 |
Arnold, JD; Berger, AE; Fencik, M; Hart, K; Hayden, DM; March, L; Mullane, JF; Perdomo, CA | 1 |
Frank, JE; Gaston, GW; Mallow, RD | 1 |
Dainaka, J; Hashii, H; Inoue, K; Kimura, K; Motonaga, A; Nishimura, T; Ueda, F; Yamate, K | 1 |
Levy, DJ | 1 |
Kanno, T; Kikuchi, H; Nishihara, K; Sarashina, T; Tanabe, S; Uzuka, Y | 1 |
Cryer, B; Cung, A; Kazi, S; Kelly, KC; Little, BB; Roberts, KW; Sarosi, GA; Smith, HJ; Weideman, RA | 1 |
Alem, MA; Douglas, LJ | 1 |
Khan, NK; Radi, ZA | 1 |
Robak, P; Robak, T; Smolewski, P | 1 |
Hisatome, I; Kita, Y; Shimizu, T; Tanaka, K; Tsujimoto, S; Uozumi, N; Yamamoto, Y; Yoshida, A | 1 |
Akagi, Y; Aoyama, T; Nio, Y; Shimada, S | 1 |
Kanbayashi, Y; Konishi, H | 1 |
Hasegawa, H; Hirono, J; Kitada, K; Lie, LK; Nakagawa, K; Sada, H; Sanaki, H; Segi-Nishida, E; Suzuki, A | 1 |
Hasegawa, H; Hohjoh, H; Inazumi, T; Konishi, M; Maharjan, BD; Nakagawa, K; Razali, N; Sugimoto, Y | 1 |
5 review(s) available for aspirin and etodolac
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Etodolac: analgesic effects in musculoskeletal and postoperative pain.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Aspirin; Athletic Injuries; Back Pain; Bursitis; Diclofenac; Dose-Response Relationship, Drug; Etodolac; Humans; Indoleacetic Acids; Musculoskeletal System; Naproxen; Pain, Postoperative; Piroxicam; Tendinopathy | 1990 |
Etodolac. A preliminary review of its pharmacodynamic activity and therapeutic use.
Topics: Acetates; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Etodolac; Humans; Kinetics; Osteoarthritis; Pain, Postoperative | 1986 |
Effects of cyclooxygenase inhibition on the gastrointestinal tract.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clonixin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Etodolac; Gastrointestinal Tract; Humans; Indomethacin; Naproxen; Species Specificity | 2006 |
The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Etodolac; Hematologic Neoplasms; Heterocyclic Compounds, 3-Ring; Humans | 2008 |
11 trial(s) available for aspirin and etodolac
Article | Year |
---|---|
Etodolac: analgesic effects in musculoskeletal and postoperative pain.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Aspirin; Athletic Injuries; Back Pain; Bursitis; Diclofenac; Dose-Response Relationship, Drug; Etodolac; Humans; Indoleacetic Acids; Musculoskeletal System; Naproxen; Pain, Postoperative; Piroxicam; Tendinopathy | 1990 |
Minimum effective dose of etodolac for the treatment of rheumatoid arthritis.
Topics: Acetates; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Etodolac; Female; Humans; Male; Middle Aged; Random Allocation; Time Factors | 1986 |
The effect of etodolac administration on renal function in patients with arthritis.
Topics: Acetates; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Blood Urea Nitrogen; Clinical Trials as Topic; Creatinine; Double-Blind Method; Etodolac; Humans; Ibuprofen; Kidney Function Tests; Middle Aged; Osteoarthritis; Sulindac | 1986 |
Etodolac compared with aspirin: an endoscopic study of the gastrointestinal tracts of normal volunteers.
Topics: Acetates; Adolescent; Adult; Aspirin; Dose-Response Relationship, Drug; Duodenitis; Endoscopy; Etodolac; Female; Gastric Mucosa; Gastritis; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Intestinal Mucosa; Male; Middle Aged; Occult Blood; Random Allocation | 1986 |
Etodolac--a new NSAID for rheumatoid arthritis.
Topics: Acetates; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Double-Blind Method; Etodolac; Humans | 1987 |
Etodolac in postsurgical pain: a double-blind dose-ranging efficacy study with aspirin and placebo.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Etodolac; Female; Humans; Male; Middle Aged; Pain, Postoperative; Placebos | 1982 |
Twelve-week study of etodolac, aspirin, and placebo in patients with rheumatoid arthritis.
Topics: Acetates; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Etodolac; Female; Humans; Male; Middle Aged; Patient Compliance | 1983 |
Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study.
Topics: Acetates; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Etodolac; Female; Humans; Male; Middle Aged; Placebos; Random Allocation | 1983 |
Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study.
Topics: Acetates; Adult; Aged; Anti-Inflammatory Agents; Aspirin; Clinical Trials as Topic; Double-Blind Method; Etodolac; Female; Humans; Male; Middle Aged; Osteoarthritis; Patient Compliance; Placebos | 1983 |
Etodolac, aspirin, and gastrointestinal microbleeding.
Topics: Acetates; Adult; Aspirin; Dose-Response Relationship, Drug; Drug Evaluation; Etodolac; Gastrointestinal Hemorrhage; Humans; Male; Occult Blood; Random Allocation | 1984 |
The efficacy of etodolac for patients with pain following oral surgery.
Topics: Acetates; Adolescent; Adult; Aged; Analgesics; Aspirin; Clinical Trials as Topic; Double-Blind Method; Etodolac; Female; Humans; Male; Middle Aged; Pain, Postoperative; Placebos; Random Allocation; Time Factors; Tooth Extraction | 1984 |
24 other study(ies) available for aspirin and etodolac
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Drug Design; Enzyme Inhibitors; Humans; Hydroxyprostaglandin Dehydrogenases; Molecular Structure; Tumor Cells, Cultured | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Self-organizing molecular field analysis of NSAIDs: assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Computational Biology; Least-Squares Analysis; Models, Molecular; Molecular Conformation; Quantitative Structure-Activity Relationship | 2012 |
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; CHO Cells; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Synergistic effect of tolfenamic acid and glycyrrhizic acid on TPA-induced skin inflammation in mice.
Topics: | 2019 |
In vitro effects of Etodolac and acetylsalicylic acid on human chondrocyte metabolism.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cartilage, Articular; Collagen; Dinoprostone; DNA; Etodolac; Humans; Indoleacetic Acids; Proteoglycans; Radioimmunoassay | 1992 |
Cell damage unmasks 15-lipoxygenase activity in human neutrophils.
Topics: Acetates; Arachidonate Lipoxygenases; Aspirin; Dose-Response Relationship, Drug; Etodolac; Fluorometry; Flurbiprofen; Humans; Hydroxyeicosatetraenoic Acids; Ibuprofen; L-Lactate Dehydrogenase; Lipoxygenase; Naproxen; Neutrophils; Phenylbutazone | 1985 |
The effectiveness of 100 and 200 mg etodolac (Ultradol), aspirin, and placebo in patients with pain following oral surgery.
Topics: Acetates; Adolescent; Adult; Analgesics; Aspirin; Double-Blind Method; Etodolac; Female; Humans; Male; Middle Aged; Molar, Third; Pain, Postoperative; Placebos; Random Allocation; Time Factors; Tooth Extraction | 1983 |
Effect of etodolac on articular and bone pathology associated with adjuvant arthritis in rats: a comparison with aspirin and naproxen.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Aspirin; Bone and Bones; Cartilage, Articular; Drug Evaluation, Preclinical; Etodolac; Male; Naproxen; Rats; Rats, Inbred Lew | 1984 |
Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation.
Topics: Animals; Aspirin; Bradykinin; Bromelains; Cartilage, Articular; Cell Line; Concanavalin A; Depression, Chemical; Diclofenac; Dinoprostone; Dogs; Etodolac; Gastric Mucosa; Guinea Pigs; Indomethacin; Interleukin-1; Ketoprofen; Kidney; Naproxen; Oxygen; Pain; Piroxicam; Rabbits; Rats | 1994 |
Images in clinical medicine. An aspirin tablet and a gastric ulcer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Etodolac; Female; Foreign Bodies; Gastroscopy; Humans; Pyloric Antrum; Stomach Ulcer | 2000 |
Comparison of the upper gastrointestinal effects of etodolac and aspirin in healthy dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dogs; Endoscopy, Gastrointestinal; Etodolac; Gastric Mucosa; Intestinal Mucosa; Male; Random Allocation; Statistics, Nonparametric | 2001 |
Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Cyclooxygenase Inhibitors; Etodolac; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naproxen | 2004 |
Prostaglandin production during growth of Candida albicans biofilms.
Topics: Aspirin; Biofilms; Candida albicans; Cyclooxygenase Inhibitors; Diclofenac; Etodolac; Microscopy, Electron, Scanning; Morphogenesis; Prostaglandins; Signal Transduction; Virulence Factors | 2005 |
The cyclooxygenase-2 selective inhibitor, etodolac, but not aspirin reduces neovascularization in a murine ischemic hind limb model.
Topics: Animals; Aspirin; Bone Marrow Cells; Cell Transplantation; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Eicosanoids; Etodolac; Gene Expression Regulation, Enzymologic; Group IV Phospholipases A2; Hindlimb; Ischemia; Leukocytes, Mononuclear; Male; Mice; Neovascularization, Physiologic; Regional Blood Flow | 2010 |
Influence of nonsteroidal anti-inflammatory drugs on the antiplatelet effects of aspirin in rats.
Topics: Acetylation; Adenosine Diphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Collagen; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Drug Interactions; Etodolac; Ibuprofen; Male; Phenylpropionates; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 2011 |
Predictive Factors for NSAIDs-related Gastrointestinal Toxicity: Can COX-2 Selective Inhibtor Prevent it?.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplastic Agents; Aspirin; Celecoxib; Cohort Studies; Cyclooxygenase 2 Inhibitors; Diclofenac; Duodenal Diseases; Duodenal Ulcer; Endoscopy, Digestive System; Etodolac; Female; Humans; Logistic Models; Male; Middle Aged; Phenylpropionates; Protective Factors; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Stomach Diseases; Stomach Ulcer | 2015 |
Expression of tissue inhibitor of metalloproteinases and matrix metalloproteinases in the ischemic brain of photothrombosis model mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain; Disease Models, Animal; Endothelial Cells; Etodolac; Gene Expression; Inflammation; Ischemia; Male; Matrix Metalloproteinases; Mice, Inbred C57BL; RNA, Messenger; Stroke; Tissue Inhibitor of Metalloproteinases; Up-Regulation | 2018 |
Induced Prostanoid Synthesis Regulates the Balance between Th1- and Th2-Producing Inflammatory Cytokines in the Thymus of Diet-Restricted Mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Caloric Restriction; Cytokines; Diet; Etodolac; Male; Mice, Inbred ICR; Organ Size; Prostaglandins; Th1 Cells; Th2 Cells; Thymus Gland | 2020 |